ACCESS Newswire

Nexa Resources S.A.

Share
Nexa Reports Second Quarter Exploration Results

Nexa Resources S.A. ("Nexa Resources", "Nexa", or "Company") is pleased to provide today the drilling and assay results from the second quarter of 2021. This document contains forward-looking statements

LUXEMBOURG / ACCESSWIRE / July 21, 2021 / Nexa's Mineral Exploration program for 2021 comprises a total of 111,000 meters of exploratory drilling, of which 26,533 meters were executed in the second quarter of 2021 through 21 operating drill rigs, totaling 44,404 meters of exploratory drilling in 1H21. The program in Peru accounts for 69,000 meters, in Brazil for 30,000 meters and in Namibia for 12,000 meters.

In Peru, 23,131 meters were drilled in 2Q21 with 14 rigs, totaling 33,998 meters in 1H21. At the Pasco Complex, the exploration was focused at the Sara Sur target in El Porvenir with thick and high grade new intersections. At Cerro Lindo, drilling in 2Q21 has remained focused at the Pucasalla target, aiming to expand the new VMS discovery at the site and near mine underground ore body expansion at orebody 9 and 5B.

In Brazil, 2,785 meters of exploratory drilling was executed with 5 rigs in 2Q21, totaling 7,555 meters in 1H21. At Aripuanã, exploratory drilling has been focused on northwest extension at Babaçu and new drilling continues to confirm a high-grade mineralization area.

In Namibia, 617 meters were drilled in 2Q21 with 2 rigs, totaling 2,851 meters in 1H21. Exploratory drilling was focused on exploratory targets at the Otavi and Namibia North projects.

2Q21 Mineral Exploration Highlights

  • In Cerro Lindo, drilling results continue to confirm continuity of orebody 9 after 1,332 meters drilled with thick intersections such as 23 meters with 13.38% ZnEq and 17 meters with 7.79% ZnEq.
  • The new discovery of VMS mineralization at the Pucasalla target located 4.5 kilometers northwest of the Cerro Lindo mine revealed thick intersections such as 24.9 meters with 5.66% ZnEq and 19.7 meters with 12.85% ZnEq.
  • In El Porvenir, drilling activities continue to confirm lateral extensions of the Sara orebody. At Sara Sur, target thick intersections up to 42 meters @ 17.30% ZnEq were confirmed as a result of drilling.
  • At Vazante Extremo Norte, the continuity of willemite mineralization was confirmed in a northwest Varginha parallel trend to the main orebody.
  • In Morro Agudo, we have confirmed that the Bonsucesso mineralized zone extends at depth along a parallel southwestern trend.
  • At Aripuanã, exploratory drilling continued at the deep northwest extension of Babaçu, confirming massive sulfide VMS mineralization. Highlight to drill hole BRAPD000080 along with a broad 400 meters interval including 147,1 meters with 5.61% ZnEq.
  • At Hilarión, drilling confirmed two major orebodies at Hilarión Sur target, the southern extension of the Hilarion deposit. Continuity was confirmed over 180 meters in length, 500 meters in height and 6 to 25 meters in width after 7,218 meters drilled in 2Q21.

"During 2Q21, we have continued to produce significant results in all our brownfield exploration programs," commented Jones Belther, Senior Vice-President Mineral Exploration & Technology. "We continue extending the Cerro Lindo ore bodies to the southeast with thick and high grade intersections in orebody 9 opening up a promising mineralized body extension and discovering new mineralized zones like Pucasalla. Pucasalla is the first relevant discovery north of Topará Creek and it opens up a new ground for resource definition and possible reserve increase and life of mine extension for Cerro Lindo. This mineralized body is completely blind at 400 meters vertical depth and it was spotted by geophysics (Quantec Titan electromagnetics survey). It is being outlined in one drill section hosted in a horizontal volcaniclastic rocks layer with a width greater than 250 meters with variable thickness of 5 meters up to 25 meters. The first assay results for Pucasalla are very encouraging, indicating a high-grade mineralized zone.

At the Pasco complex, the Sara orebody continues to be extended to the north and south, with thick and high grade drill intersection in Sara Sur, and in San Gerardo open pit, we obtained several new positive drill intersections. In Vazante, the Varginha Norte trend is being extended to the north and at Morro Agudo/Bonsucesso, the parallel trend continues revealing positive results along strike and at depth.

In Aripuanã, the Babaçu NW confirmed thick intersections with good grades. In Hilarión, new drilling results are confirming thick and continuous bodies in the southern extension of the Hilarión deposit.

These results confirm Nexa is on the right path to grow and extend the mine life of our operations and increment resources of our project portfolio."

For a full version of this document, please go to our Investor Relations website at: http://ir.nexaresources.com

About Nexa

Nexa is a large-scale, low-cost integrated zinc producer with over 60 years of experience developing and operating mining and smelting assets in Latin America. Nexa currently owns and operates five long-life underground mines - three located in the Central Andes of Peru and two located in the state of Minas Gerais in Brazil - and is developing the Aripuanã Project as its sixth underground mine in Mato Grosso, Brazil. Nexa was among the top five producers of mined zinc globally in 2020 and also one of the top five metallic zinc producers worldwide in 2020, according to Wood Mackenzie.

CONTACT:
Roberta Varella
Head of Investor Relations
ir@nexaresources.com
+55 11 3405-5601

SOURCE: Nexa Resources S.A.



View source version on accesswire.com:
https://www.accesswire.com/656545/Nexa-Reports-Second-Quarter-Exploration-Results

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release

Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This

OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen

Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release

SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan

Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release

On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI

PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release

MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye